Galapagos Genomics said this week that it has appointed Philip Huxley as senior director of drug discovery.
Huxley was previously head of drug discovery at Avidex, according to Galapagos. Prior to this, he was head of molecular design at British Biotech. He holds a PhD in theoretical chemistry from the University of Sussex in Brighton.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
